Ann Beal Salamone serves as Executive at Sanara MedTech Inc., where they oversee executive responsibilities. Since joining the company, Ann Beal Salamone has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 12, 2024 involved receiving (via award) 2,949 shares valued at $0.
Ann Beal Salamone currently holds 19,895 shares of Sanara MedTech Inc. (SMTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ann Beal Salamone has been a net neutral trader of SMTI stock. They have purchased $0 and sold $0 worth of shares.
Ann Beal Salamone's most recent insider trade was on Jun 12, 2024, when they sold 2,949 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 7, 2022 | SMTI | $0 | Award | 4,113 | $N/A | Discretionary |
| Feb 9, 2022 | SMTI | $0 | Award | 3,825 | $N/A | Discretionary |
| Feb 9, 2022 | SMTI | $0 | Award | 1,912 | $N/A | Discretionary |
| Feb 9, 2022 | SMTI | $0 | Award | 2,284 | $N/A | Discretionary |
| Feb 24, 2020 | SMTI | $0 | Award | 2,410 | $N/A | Discretionary |
| Feb 10, 2020 | SMTI | $0 | Other | 2,410 | $N/A | Discretionary |
| Jan 21, 2020 | SMTI | $0 | Award | 2,410 | $N/A | Discretionary |